Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oculir
AddedFeb 15, 2024
UpdatedJun 18, 2026
Oculir

Oculir

Series A

Oculir Inc. develops non-invasive eye-based glucose meters for easy diabetes management.

HQ
San Diego, CA, US
Founded
2003
Overview
Compare
Fundraising
Employees

Oculir Inc. develops non-invasive eye-based glucose meters designed to simplify diabetes management. Their innovative technology measures glucose levels from the membrane covering the white of the eye, eliminating the need for blood samples. The company focuses on providing a more comfortable and convenient solution for diabetes patients.

Oculir's groundbreaking approach has the potential to significantly improve the quality of life for individuals with diabetes by offering a painless alternative to traditional glucose monitoring methods. The company's impact lies in its commitment to advancing diabetes care through cutting-edge technology.

Oculir - Similar Companies

OcuSciences logo

OcuSciences

ocusciences.com

GlucoVista logo

GlucoVista

glucovista.com

Newton Photonics logo

Newton Photonics

Oculogica logo

Oculogica

oculogica.com

Ocular Science logo

Ocular Science

ocularscience.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Glumetrics logo

Glumetrics

Glucon logo

Glucon

OcuDoc logo

OcuDoc

ocudocmobile.com

OcuMedic logo

OcuMedic

Glysens logo

Glysens

Ocutronics logo

Ocutronics

OcuCure Therapeutics logo

OcuCure Therapeutics

EyeIC logo

EyeIC

Diramed logo

Diramed

Oculir - Quick Facts

Who are Oculir's competitors?

Companies similar to Oculir include OcuSciences, GlucoVista, Newton Photonics and Oculogica.

When was Oculir founded?

Oculir was founded in 2003.

Where is Oculir's headquarters located?

Oculir's headquarters is located in San Diego, CA, US.

When was Oculir's last funding round?

Oculir's most recent funding round was for $7.3M (USD) in December 2005.

How much has Oculir raised to-date?

As of Dec 8, 2005, Oculir has raised a total of $7.3M (USD).

How many employees does Oculir have?

Oculir has 5 employees as of Feb 4, 2024.

Oculir - Classification

Industry
  • Hardware
  • Medical Devices
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Diabetes Management
  • Glucose Meters
Tags
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research